Sivaneswari Srinivasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sivaneswari Srinivasan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
E. Karthikeyan
2 shared publications- Akkam Sandeep
Department of Postgraduate Research in Clinical Pharmacy Santhiram College of Pharmacy India
1 shared publication B. Mounika
Department of Pharmaceutics, Jayamukhi College of Pharmacy, Warangal, Andhra Pradesh, India
1 shared publicationG. Hemalatha
Department of Pharmaceutics, Jayamukhi College of Pharmacy, Warangal, Andhra Pradesh, India
1 shared publication- Helen Williams
Translational Health Sciences, Bristol Medical School, University of Bristol, Level 7 Bristol Royal Infirmary, Bristol BS2 8HW, UK
1 shared publication J. Jayasree
Department of Pharmaceutics, Jayamukhi College of Pharmacy, Warangal, Andhra Pradesh, India
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by KEAI Publishing in Nano TransMed
- Vol. 4
Harnessing nanoparticle technology for precision medicine in head and neck cancer: Targeted delivery, immunomodulation, and clinical translation
- 1 December 2025
- Published by KEAI Publishing in Nano TransMed
- Vol. 4
Open AccessHarnessing nanoparticle technology for precision medicine in head and neck cancer: Targeted delivery, immunomodulation, and clinical translation
- Open Access
- 1 August 2025
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (4) , 277-295
Advancements in transdermal drug delivery systems: Enhancing medicine with pain-free and controlled drug release
- 1 August 2025
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (4) , 277-295
Open AccessAdvancements in transdermal drug delivery systems: Enhancing medicine with pain-free and controlled drug release
- 27 March 2025
- Published by Springer Nature in Biomedical Materials & Devices
- Vol. 4 (2) , 1245-1262
Artificial Intelligence in Personalized Medicine for Head and Neck Cancer: Optimizing Prescriptions and Treatment Planning
- 27 March 2025
- Published by Springer Nature in Biomedical Materials & Devices
- Vol. 4 (2) , 1245-1262
Artificial Intelligence in Personalized Medicine for Head and Neck Cancer: Optimizing Prescriptions and Treatment Planning
- Open Access
- 30 December 2023
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 21 (4) , 785-792
Prevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease
Introduction and aim. Anaemia is a chronic kidney disease (CKD) condition characterised by a decline in glomerular filtration rate (GFR) and impaired kidney function. The aim of this study was to assess the prevalence, prescribing patterns, and quality of life of anaemia in patients with chronic renal disease who were adults (>18 years of age) at a tertiary care hospital. Material and methods. Data on demographic characteristics, laboratory results, medication prescriptions, and quality of life assessments were collected. Statistical tests were performed to determine associations between anaemia prevalence and factors like age, gender, and CKD stage. The study included 132 patients, with a gender distribution of 89 men and 43 women. Results. The most frequently prescribed drugs are epoetin (15.06%), multivitamins (14.82%), iron (10.65%), folic acid (10.22%), calcium carbonate (8.17%), calcitriol (5.6%), and omeprazole (4.22%). The cardiovascular system, blood disorders, and blood-producing organs come after the gastrointestinal tract and metabolism in the first anatomical level of the ATC classification. Conclusion. It suggests hospital audits and recommendations for improved prescription practices. Further investigation into anaemia causes and drug class appropriateness is needed, and implementing improvements could potentially improve health outcomes.
- 30 December 2023
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 21 (4) , 785-792
Open AccessPrevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease
Introduction and aim. Anaemia is a chronic kidney disease (CKD) condition characterised by a decline in glomerular filtration rate (GFR) and impaired kidney function. The aim of this study was to assess the prevalence, prescribing patterns, and quality of life of anaemia in patients with chronic renal disease who were adults (>18 years of age) at a tertiary care hospital. Material and methods. Data on demographic characteristics, laboratory results, medication prescriptions, and quality of life assessments were collected. Statistical tests were performed to determine associations between anaemia prevalence and factors like age, gender, and CKD stage. The study included 132 patients, with a gender distribution of 89 men and 43 women. Results. The most frequently prescribed drugs are epoetin (15.06%), multivitamins (14.82%), iron (10.65%), folic acid (10.22%), calcium carbonate (8.17%), calcitriol (5.6%), and omeprazole (4.22%). The cardiovascular system, blood disorders, and blood-producing organs come after the gastrointestinal tract and metabolism in the first anatomical level of the ATC classification. Conclusion. It suggests hospital audits and recommendations for improved prescription practices. Further investigation into anaemia causes and drug class appropriateness is needed, and implementing improvements could potentially improve health outcomes.
- Open Access
- 1 January 2014
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 4 (4) , 183-188
Role of various natural, synthetic and semi-synthetic polymers on drug release kinetics of losartan potassium oral controlled release tablets
Objective: The objective of the present work was to formulate and to characterize controlled release matrix tablets of losartan potassium in order to improve bioavailability and to minimize the frequency of administration and increase the patient compliance. Materials and Methods: Losartan potassium controlled release matrix tablets were prepared by direct compression technique by the use of different natural, synthetic and semisynthetic polymers such as gum copal, gum acacia, hydroxypropyl methyl cellulose K100 (HPMC K100), eudragit RL 100 and carboxy methyl ethyl cellulose (CMEC) individually and also in combination. Studies were carried out to study the inf uence of type of polymer on drug release rate. All the formulations were subjected to physiochemical characterization such as weight variation, hardness, thickness, friability, drug content, and swelling index. In vitro dissolution studies were carried out simulated gastric f uid (pH 1.2) for first 2 h and followed by simulated intestinal fluid (pH 6.8) up to 24 h, and obtained dissolution data were fitted to in vitro release kinetic equations in order to know the order of kinetics and mechanism of drug release. Results and Discussion: Results of physiochemical characterization of losartan potassium matrix tablets were within acceptable limits. Formulation containing HPMC K100 and CMEC achieved the desired drug release profile up to 24 h followed zero order kinetics, release pattern dominated by Korsmeyer — Peppas model and mechanism of drug release by nonf ckian diffusion. The good correlation obtained from Hixson-Crowell model indicates that changes in surface area of the tablet also influences the drug release. Conclusion: Based on the results, losartan potassium controlled release matrix tablets prepared by employing HPMC K100 and CMEC can attain the desired drug release up to 24 h, which results in maintaining steady state concentration and improving bioavailability.
- 1 January 2014
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 4 (4) , 183-188
Open AccessRole of various natural, synthetic and semi-synthetic polymers on drug release kinetics of losartan potassium oral controlled release tablets
Objective: The objective of the present work was to formulate and to characterize controlled release matrix tablets of losartan potassium in order to improve bioavailability and to minimize the frequency of administration and increase the patient compliance. Materials and Methods: Losartan potassium controlled release matrix tablets were prepared by direct compression technique by the use of different natural, synthetic and semisynthetic polymers such as gum copal, gum acacia, hydroxypropyl methyl cellulose K100 (HPMC K100), eudragit RL 100 and carboxy methyl ethyl cellulose (CMEC) individually and also in combination. Studies were carried out to study the inf uence of type of polymer on drug release rate. All the formulations were subjected to physiochemical characterization such as weight variation, hardness, thickness, friability, drug content, and swelling index. In vitro dissolution studies were carried out simulated gastric f uid (pH 1.2) for first 2 h and followed by simulated intestinal fluid (pH 6.8) up to 24 h, and obtained dissolution data were fitted to in vitro release kinetic equations in order to know the order of kinetics and mechanism of drug release. Results and Discussion: Results of physiochemical characterization of losartan potassium matrix tablets were within acceptable limits. Formulation containing HPMC K100 and CMEC achieved the desired drug release profile up to 24 h followed zero order kinetics, release pattern dominated by Korsmeyer — Peppas model and mechanism of drug release by nonf ckian diffusion. The good correlation obtained from Hixson-Crowell model indicates that changes in surface area of the tablet also influences the drug release. Conclusion: Based on the results, losartan potassium controlled release matrix tablets prepared by employing HPMC K100 and CMEC can attain the desired drug release up to 24 h, which results in maintaining steady state concentration and improving bioavailability.